The biotechnology giant has not ruled out expanding its pipeline of treatments through acquisitions after a number of ...

Thanks to mass immunization campaigns, by the year 2000, measles, once a common childhood illness with severe complications, ...

Last month, the US Food and Drug Administration (FDA) cautioned ... are developing a vaccine to stop people being religious, ...

A vaccine against fentanyl—yes! Finally, a truly novel approach to SUDs is currently under development and hopefully will ...

The new lab was announced at the HLTH conference in Las Vegas this week, said Parminder Bhatia, GE HealthCare’s chief AI ...

In last week’s column, I told you how the 2024 General Election (early voting has started) could lead to healthier, smarter, and longer lives for all of us (see: ...

On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...

And FDA said that Boston Scientific has again issued new instructions for its Obsidio Conformable Embolic after 15 injuries ...

Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines, has presented positive clinical safety and immunogenicity data from a clinical phase 1 study of ...

BioNTech's oncology assets, including BNT327/PM8002, show promising results. Read why I maintain my buy rating on BNTX stock.

However, Novavax's shares recently dropped by about 20% in one day after it announced a clinical setback. The biotech's stock ...